# Novel Digital Application for Patients With Acute Leukemia

> **NCT06472128** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Relapsed Adult Acute Myeloid Leukemia
- Primary Refractory Acute Myeloid Leukemia
- High Risk Acute Myeloid Leukemia

## Interventions

- **BEHAVIORAL:** DREAMLAND
- **BEHAVIORAL:** VITAL WELLNESS

## Key facts

- **NCT ID:** NCT06472128
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-21
- **Primary completion:** 2029-04-30
- **Final completion:** 2030-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472128, "Novel Digital Application for Patients With Acute Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06472128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*